Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Thinking Beyond Cholesterol Deficiency
- 28 December 2009
- book chapter
- review article
- Published by Springer Science and Business Media LLC in Advances in experimental medicine and biology
- Vol. 664, 481-489
- https://doi.org/10.1007/978-1-4419-1399-9_55
Abstract
Smith-Lemli-Opitz Syndrome (SLOS) is a recessive hereditary disease caused by a defect in the last step in cholesterol biosynthesis – the reduction of the Δ7 double bond of 7-dehydrocholesterol (7DHC) – resulting in the abnormal accumulation of 7DHC and diminished levels of Chol in all bodily tissues. Treatment of rats with AY9944 – a drug that inhibits the same enzyme that is genetically defective in SLOS (i.e., DHCR7, 3β-hydroxysterol-Δ7-reductase) – starting in utero and continuing throughout postnatal life, provides a convenient animal model of SLOS for understanding the disease mechanism and also for testing the efficacy of therapeutic intervention strategies. Herein, the biochemical, morphological, and electrophysiological hallmarks of retinal degeneration in this animal model are reviewed. A high-cholesterol diet partially ameliorates the associated visual function deficits, but not the morphological degeneration. Recent studies using this model suggest that the disease mechanism in SLOS goes well beyond the initial cholesterol pathway defect, including global metabolic alterations, lipid and protein oxidation, and differential expression of hundreds of genes in multiple ontological gene families. These findings may have significant implications with regard to developing more optimal therapeutic interventions for managing SLOS patients.Keywords
This publication has 23 references indexed in Scilit:
- Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndromeJournal of Lipid Research, 2008
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitorsBritish Journal of Pharmacology, 2008
- Lipidomic analysis of the retina in a rat model of Smith–Lemli–Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular speciesJournal of Neurochemistry, 2007
- Partial Rescue of Retinal Function and Sterol Steady-State in a Rat Model of Smith-Lemli-Opitz SyndromePediatric Research, 2007
- Recent insights into the Smith–Lemli–Opitz syndromeClinical Genetics, 2005
- Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndromeThe Journal of Pediatrics, 1995
- Cholesterol and the cell membraneBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1985
- The function of sterols in membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1976
- A newly recognized syndromeof multiple congenital anomaliesThe Journal of Pediatrics, 1964
- A Novel Mode of Inhibition of Cholesterol BiosynthesisJournal of the American Chemical Society, 1963